Aurealis Therapeutics attended LSX World Congress USA, 16-17 September 2025 in Boston. This was a leading forum that brought together innovators, investors, and senior life science dealmakers to shape the future of healthcare.
Representing Aurealis Therapeutics were Juha Yrjänheikki (CEO) and Laurent Décory (COO). Our team also had a presentation on Wednesday, 17 September at 12:45, where our multi-target technology platform and the latest clinical advancements from our pipeline were presented.
🔗 Interested to hear more? Book a meeting with us!